Cybin (HELP) Cash from Operations (2020 - 2026)
Cybin's (HELP) quarterly Cash from Operations came in at 37291000.0 in Q1 2026, down 153.44% YoY from 69782442.13 in Q1 2025, and down 16.73% on a QoQ basis from 31947000.0 in Q4 2025.
Cybin (HELP) Cash from Operations (2020 - 2026) Analysis & Trends
Cybin (HELP) has 7 years of Cash from Operations data on file, last reported at 37291000.0 in Q1 2026.
- Quarterly Cash from Operations fell 153.44% year-over-year to 37291000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 133271000.0 (down 84.31% YoY) and the FY2026 annual result came in at 133271000.0, down 84.26% from the prior year.
- Cash from Operations fell to 37291000.0 in Q1 2026, from 31947000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 4960037.03 in Q2 2022 to a low of 37291000.0 in Q1 2026.
- A 5-year average of 18054856.29 and a median of 18593000.0 in 2024 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2023 — Cash from Operations gained 24.05% — and 2026, when it plunged 153.44%.
- Tracing HELP's Cash from Operations over 5 years: stood at 7935027.37 in 2022, then plunged by 141.07% to 19128774.2 in 2023, then climbed by 2.8% to 18593000.0 in 2024, then plunged by 71.82% to 31947000.0 in 2025, then declined by 16.73% to 37291000.0 in 2026.
- The last three Cash from Operations figures came in at 37291000.0 (Q1 2026), 31947000.0 (Q4 2025), and 34485000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -387.32 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 462.82 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 728.46 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 326.72 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Cybin | 417.29 Mn | 417.29 Mn | - | -37.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.29 Mn |
| Mar 31, 2026 | -37.29 Mn |
| Dec 31, 2025 | -31.95 Mn |
| Dec 31, 2025 | -31.95 Mn |
| Sep 30, 2025 | -34.49 Mn |
| Sep 30, 2025 | -34.49 Mn |
| Jun 30, 2025 | -29.55 Mn |
| Jun 30, 2025 | -29.55 Mn |
| Mar 31, 2025 | -14.71 Mn |
| Mar 31, 2025 | -14.71 Mn |
| Dec 31, 2024 | -18.59 Mn |
| Dec 31, 2024 | -18.59 Mn |
| Sep 30, 2024 | -19.11 Mn |
| Sep 30, 2024 | -19.11 Mn |
| Jun 30, 2024 | -19.89 Mn |
| Jun 30, 2024 | -19.89 Mn |
| Mar 31, 2024 | -15.37 Mn |
| Mar 31, 2024 | -15.37 Mn |
| Dec 31, 2023 | -19.13 Mn |
| Dec 31, 2023 | -19.13 Mn |